INSIGHTS ON UPSTREAM MANUFACTURING

• Cell Culture Supplements To Accelerate Stable Cell Line Development

  Here, we demonstrate the ability of animal component-free Insti CHO and HEK cell culture supplements to enable the industry to overcome cell culture limitations while meeting regulatory requirements.

• Genome Editing Using mRNA-Lipid Nanoparticles For CAR T Cell Therapy

  Gene delivery platforms must support a diversity of genetic engineering strategies for genomic medicine development. Learn how lipid nanoparticles can accelerate development from discovery to scale-up.

• Assay For Rapid Lot-Release Testing In Cell Therapies

  Learn how PCR-based Mycoplasma detection assays can provide a rapid alternative to culturing with comparable sensitivity, specificity, and species range that can facilitate quick decision-making.

• Rapid Mycoplasma Detection For Bioproduction Sample Testing

  Streamline your workflow while enabling early and accurate detection of mycoplasma contamination with mycoplasma detection and sample preparation kits

• Overcoming Bioprocessing Bottlenecks By Combining Adherent And Suspension Systems

  11/20/2023

  In a recent internal study, Waisman Biomanufacturing was able to demonstrate comparability for a new manufacturing platform combining bioreactors and microcarriers using mesenchymal stromal cells.

• Bioreactor Scaling Made Simpler

  11/16/2023

  Gain insight into how digital standardized tools can streamline your scaling processes and enable more accurate prediction and visualization of your scaling needs.

• What Is A P&ID And How Can I Use It To Understand My Bioreactor Better?

  11/14/2023

  Learn how to interpret a P&ID in order to understand the functionalities of your bioreactor and its capabilities.

• Ready To Amplify Plasmid (pDNA) In Bacteria?

  11/14/2023

  Explore how to use and amplify pDNA from the development of recombinant proteins and viral vectors to advanced bio-therapeutics such as mRNA vaccines.